Literature DB >> 27172158

Reduced Immunocompetent B Cells and Increased Secondary Infection in Elderly Patients With Severe Sepsis.

Kodai Suzuki1, Shigeaki Inoue, Yoshie Kametani, Yukako Komori, Sayuri Chiba, Takehito Sato, Sadaki Inokuchi, Shinji Ogura.   

Abstract

Lymphocyte exhaustion was recently recognized as a mechanism of immunosuppression in sepsis. While B cells are known to play pivotal roles in bacterial infection and sepsis, changes in B-cell-mediated humoral immunity have not been evaluated in critically ill septic patients. We aimed to investigate changes in humoral immunity caused by defective B-cell function during severe sepsis. Thirty-three severe sepsis patients and 44 healthy subjects were prospectively enrolled. Blood was collected from patients within 72 h of and 8 to 11 h after sepsis onset to measure B-cell subtypes, serum immunoglobulin M concentration, and CpG-B oligodeoxynucleotide-induced immunoglobulin M (IgM) production ex vivo. Participants were divided into two age groups: adults (18-64 years) and elderly (≥65 years). The fraction of CD21 exhausted B cells in acute sepsis patients (3.18%) was higher than that observed in healthy donors (0.77%, respectively, P <0.01). Significantly, serum IgM in elderly septic patients (≥65 years) was negatively correlated with acute physiology and chronic health evaluation II score (r = -0.57, P <0.05). Consistently, in B cells stimulated ex vivo, both aging and sepsis induced significant reductions in supernatant IgM (P <0.01). This finding was clinically relevant, as elderly patients with decreased IgM production might be more susceptible to infection by Gram-negative bacteria and fungi. Reduced immunocompetent B cells may be related to increased secondary infection after sepsis, especially in the elderly. Finally, impaired humoral immunity with increased CD21 exhausted B cells and insufficient immunoglobulin M production may be a critical immunological change in sepsis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27172158     DOI: 10.1097/SHK.0000000000000619

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  16 in total

1.  Epidemiology and outcome of elderly admitted to the ward for sepsis.

Authors:  A Pyrpasopoulou; P Pateinakis; A Varouktsi; E Georgianou; I Zografou; E Roilides; A Karagiannis
Journal:  Hippokratia       Date:  2016 Oct-Dec       Impact factor: 0.471

Review 2.  Advances in the understanding and treatment of sepsis-induced immunosuppression.

Authors:  Fabienne Venet; Guillaume Monneret
Journal:  Nat Rev Nephrol       Date:  2017-12-11       Impact factor: 28.314

Review 3.  The immune system's role in sepsis progression, resolution, and long-term outcome.

Authors:  Matthew J Delano; Peter A Ward
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 4.  The importance of a sepsis layered early warning system for critical patients.

Authors:  Hui Lian; Hongmin Zhang; Xin Ding; Xiaoting Wang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

5.  Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study.

Authors:  Yukihiro Ando; Shigeaki Inoue; Takahisa Kawashima; Masahiro Okashiro; Joji Kotani; Takashi Nishiyama
Journal:  Kobe J Med Sci       Date:  2020-06-08

6.  Neutrophil Elastase Inhibition Ameliorates Endotoxin-induced Myocardial Injury Accompanying Degradation of Cardiac Capillary Glycocalyx.

Authors:  Tetsuya Fukuta; Hideshi Okada; Genzou Takemura; Kodai Suzuki; Chihiro Takada; Hiroyuki Tomita; Akio Suzuki; Kazumasa Oda; Akihiro Uchida; Saori Matsuo; Hirotsugu Fukuda; Hirohisa Yano; Isamu Muraki; Ryogen Zaikokuji; Ayumi Kuroda; Ayane Nishio; So Sampei; Nagisa Miyazaki; Yasuaki Hotta; Noriaki Yamada; Takatomo Watanabe; Kentaro Morishita; Tomoaki Doi; Takahiro Yoshida; Hiroaki Ushikoshi; Shozo Yoshida; Yoichi Maekawa; Shinji Ogura
Journal:  Shock       Date:  2020-09       Impact factor: 3.533

Review 7.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 8.  Diabetes and Sepsis: Risk, Recurrence, and Ruination.

Authors:  Lynn M Frydrych; Fatemeh Fattahi; Katherine He; Peter A Ward; Matthew J Delano
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-30       Impact factor: 5.555

9.  Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study.

Authors:  Fei Pei; Guan-Rong Zhang; Li-Xin Zhou; Ji-Yun Liu; Gang Ma; Qiu-Ye Kou; Zhi-Jie He; Min-Ying Chen; Yao Nie; Jian-Feng Wu; Xiang-Dong Guan
Journal:  Infect Drug Resist       Date:  2020-06-30       Impact factor: 4.003

10.  B-cell dynamics during experimental endotoxemia in humans.

Authors:  Alexandra Brinkhoff; Ye Zeng; Annette Sieberichs; Sebastian Dolff; Xu Shilei; Ming Sun; Harald Engler; Sven Benson; Johannes Korth; Manfred Schedlowski; Andreas Kribben; Oliver Witzke; Benjamin Wilde
Journal:  Biosci Rep       Date:  2019-05-17       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.